Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI trial)

American Journal of Cardiology

Volumn 109, Issue 6, 2012, Pages 805-812

  Mehta, Rajendra H ^a   Yu, Jennifer ^b   Piccini, Jonathan P ^a   Tcheng, James E ^a   Farkouh, Michael E ^b   Reiffel, James ^c   Fahy, Martin ^c   Mehran, Roxana ^b   Stone, Gregg W ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BALLOON; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SURVIVAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; UNITED STATES; VENTRICULAR FIBRILLATION;

EID: 84857794627     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.10.043     Document Type: Article

References (19)

1. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
2. R.H. Mehta, K.J. Harjai, D.A. Cox, G.W. Stone, B.R. Brodie, J. Boura, L. Grines, W. O'Neill, C.L. Grines Primary Angioplasty in Myocardial Infarction investigators Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 96 2005 901 906 (Pubitemid 41362510)
3. R.H. Mehta, W.W. O'Neill, K.J. Harjai, J. Boura, D.A. Fox, B.R. Brodie, G.W. Stone, C.L. Grines, C.L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) and the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Prediction of one-year Mortality among 30-day survivors after primary percutaneous coronary interventions Am J Cardiol 97 2006 817 822
4. S. Addala, C.L. Grines, S.R. Dixon, G.W. Stone, J.A. Boura, A.B. Ochoa, G. Pellizzon, W.W. O'Neill, J.K. Kahn Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score) Am J Cardiol 93 2004 629 632 (Pubitemid 38293076)
5. A. Halkin, M. Singh, E. Nikolsky, C.L. Grines, J.E. Tcheng, E. Garcia, D.A. Cox, M. Turco, T.D. Stuckey, Y. Na, A.J. Lansky, B.J. Gersh, W.W. O'Neill, R. Mehran, G.W. Stone Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score J Am Coll Cardiol 45 2005 1397 1405 (Pubitemid 40615609)
6. G. Parodi, G. Memisha, R. Valenti, M. Trapani, A. Migliorini, G.M. Santoro, D. Antoniucci Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience Heart 91 2005 1541 1544 (Pubitemid 41697591)
7. R.H. Mehta, K.J. Harjai, J. Boura, L. Grines, G.W. Stone, W. O'Neill, C.L. Grines, C.L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) Investigators Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes J Am Coll Cardiol 43 2004 1765 1772 (Pubitemid 38622512)
8. R.H. Mehta, A.Z. Starr, R.D. Lopes, J.S. Hochman, P. Widimsky, K.S. Pieper, P.W. Armstrong, C.B. Granger APEX AMI Investigators Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention JAMA 301 2009 1779 1789
9. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
10. R.H. Mehta, A.Z. Starr, R.D. Lopes, J.P. Piccini, M.R. Patel, K.S. Pieper, P.W. Armstrong, C.B. Granger Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk Am Heart J 161 2011 782 789
11. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, R. Hatala, E. Fain, M. Gent, S.J. Connolly DINAMIT Investigators, Defibrillator in Acute Myocardial Infarction Trial (DINAMIT) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488 (Pubitemid 39603155)
12. G. Steinbeck, D. Andresen, K. Seidl, J. Brachmann, E. Hoffmann, D. Wojciechowski, Z. Kornacewicz-Jach, B. Sredniawa, G. Lupkovics, F. Hofgrtner, A. Lubinski, M. Rosenqvist, A. Habets, K. Wegscheider, J. Senges Immediate Risk-Stratification Improves Survival (IRIS) Investigators Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
13. P.B. Berger, N.A. Ruocco, T.J. Ryan, M.M. Frederick, P.J. Podrid Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis In Myocardial Infarction (TIMI) phase II trial J Am Coll Cardiol 22 1993 1773 1779 (Pubitemid 23359630)
14. K.H. Newby, T. Thompson, A. Stebbins, E.J. Topol, R.M. Califf, A. Natale Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes The GUSTO Investigators Circulation 98 1998 2567 2573 (Pubitemid 29001196)
15. A. Volpi, A. Cavalli, E. Santoro, G. Tognoni Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarctionEvidence for a protective effect of thrombolytic therapy GISSI Investigators Circulation 82 1990 1279 1288
16. L. Jordaens, R. Tavernier MIRRACLE Investigators Determinants of sudden death after discharge from hospital for myocardial infarction in the thrombolytic era Eur Heart J 22 2001 1214 1225 (Pubitemid 32702958)
17. G.W. Stone Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention Circulation 118 2008 538 551
18. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy, S.C. Smith Jr, A.K. Jacobs, C.D. Adams, E.M. Antman, J.L. Anderson, S.A. Hunt, J.L. Halperin, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, J.L. Zamorano ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 suppl 2006 e247 e346
19. M.K. Chung, S.J. Szymkiewicz, M. Shao, E. Zishiri, M.J. Niebauer, B.D. Lindsay, P.J. Tchou Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival J Am Coll Cardiol 56 2010 194 203